Listen

Description

Why Combination Lipid-Lowering Therapy Should be Considered Early in the Treatment of Elevated LDL-C For CV Risk Reduction Mini G Varughese, MD; Matthew Deshotels, MD; Christie M. Ballantyne, MD, FACC

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease